Experienced in Peptic Ulcer

Tatehiro Kagawa

Kanagawa, JP 
Experienced in Peptic Ulcer
Kanagawa, JP 
OverviewLocationsClinical Research

Overview

Tatehiro Kagawa practices in Kanagawa, Japan. Kagawa is rated as an Experienced expert by MediFind in the treatment of Peptic Ulcer. Their top areas of expertise are Esophageal Varices, Cholestasis, Rotor Syndrome, Pancreaticoduodenectomy, and Endoscopy.

Their clinical research consists of co-authoring 120 peer reviewed articles and participating in 1 clinical trial. MediFind looks at clinical research from the past 15 years. In particular, they have co-authored 2 articles in the study of Peptic Ulcer.

Locations

Kanagawa, Japan
Other Locations
Isehara, Japan
Tokai, Japan
Sagamihara, Japan
Shimokasuya, 2591193, Japan
Toyama, 9308555, Japan
Takamatsu, Japan
Chuo, Japan
Yokosuka, Japan

Clinical Research

Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Experts who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.

1 Clinical Trials

A Two-part, Randomized, Placebo Controlled, Double Blind, Multicenter, Phase 3 Study to Evaluate the Efficacy and Safety of Linerixibat for the Treatment of Cholestatic Pruritus in Participants With Primary Biliary Cholangitis (PBC)
A Two-part, Randomized, Placebo Controlled, Double Blind, Multicenter, Phase 3 Study to Evaluate the Efficacy and Safety of Linerixibat for the Treatment of Cholestatic Pruritus in Participants With Primary Biliary Cholangitis (PBC)
Enrollment Status: Completed
Publish Date: July 22, 2025
Intervention Type: Drug
Study Drug: Linerixibat
Study Phase: Phase 3

120 Total Publications

Denosumab versus zoledronic acid for osteoporosis treatment in patients with primary biliary cholangitis (the DELTA Study): A multicenter, non-inferiority randomized trial.
Denosumab versus zoledronic acid for osteoporosis treatment in patients with primary biliary cholangitis (the DELTA Study): A multicenter, non-inferiority randomized trial.
Journal: Hepatology communications
Published: June 10, 2025

Areas of Expertise

MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.

Learn more about MediFind’s expert tiers

Find Kagawa's expertise for a condition
ConditionClose
    View All 10 Advanced Conditions
    View All 43 Experienced Conditions
    Want to save this expert for later?
    Sign Up
    Not sure about your diagnosis?
    Check Your Symptoms
     
     
     
     
    Learn about our expert tiers
    Learn More
    Are you the provider on this profile?
    Claim Profile